<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Karni Lab</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            line-height: 1.6;
        }
        header, nav, footer {
            background: #333;
            color: #fff;
            text-align: center;
            padding: 1rem;
        }
        nav a {
            color: #fff;
            margin: 0 15px;
            text-decoration: none;
        }
        .container {
            width: 80%;
            margin: auto;
            padding: 20px;
        }
        .team img {
            width: 150px;
            border-radius: 50%;
        }
        .publication, .project {
            margin-bottom: 15px;
        }
    </style>
</head>
<body>
    <header>
        <h1>Karni Lab</h1>
        <p>Exploring RNA Splicing and Cancer Therapeutics</p>
    </header>
    <nav>
        <a href="#about">About</a>
        <a href="#research">Research</a>
        <a href="#team">Team</a>
        <a href="#publications">Publications</a>
        <a href="#contact">Contact</a>
    </nav>
    <div class="container">
        <section id="about">
            <h2>About the Lab</h2>
            <p>We study how alternative RNA splicing is deregulated in cancer and genetic diseases, focusing on splicing factors' roles in disease progression and therapy development.</p>
        </section>
        <section id="research">
            <h2>Research Interests</h2>
            <p>We investigate how alternative RNA splicing is deregulated in cancer and other genetic diseases. Our key projects include:</p>
            <ul>
                <li>Identifying and characterizing splicing changes in cancer progression.</li>
                <li>Developing RNA-based therapies for neurodevelopmental genetic diseases.</li>
                <li>Targeting splicing factors for novel cancer therapies.</li>
                <li>Enhancing immunotherapy through splicing modulation.</li>
                <li>Modulating m6A RNA modifications to treat genetic diseases and cancer.</li>
            </ul>
        </section>
        <section id="team">
            <h2>Our Team</h2>
            <h3>Principal Investigator</h3>
            <p><strong>Prof. Rotem Karni</strong> - Group Leader</p>
            <p>Office: RNA Innovation Institute, One UCity Square, Room 4018</p>
            <p>Email: rotem.karni@pennmedicine.upenn.edu</p>
            
            <h3>Lab Manager</h3>
            <p><strong>Dr. Lee Roth</strong></p>
            <p>RNA Innovation Institute, One UCity Square</p>
            <p>Email: Lee.Roth@PennMedicine.upenn.edu</p>
            
            <h3>Current Members</h3>
            <p><strong>Dr. Manar Abu Diab</strong> - Postdoctoral Fellow</p>
            <p><strong>Elizabeth Talker</strong> - Ph.D. Student</p>
        </section>
        <section id="publications">
            <h2>Publications</h2>
            <p>Our research has led to multiple publications and patents, contributing to RNA-based cancer therapies. We have also founded three biotech companies: SKIP Therapeutics, Andlit Therapeutics, and RNAble.</p>
        </section>
        <section id="contact">
            <h2>Contact</h2>
            <p>Email: rotem.karni@pennmedicine.upenn.edu</p>
            <p>Office: RNA Innovation Institute, One UCity Square, Room 4018</p>
            <p>Phone: 929-501-4922</p>
        </section>
    </div>
    <footer>
        <p>&copy; 2025 Karni Lab. All Rights Reserved.</p>
    </footer>
</body>
</html># Karni-Lab-UPenn
